ACTRN12617000345381招募中1 期
A proof of concept study assessing the safety and efficacy of continuous infusion dosing of a sub-anaesthetic dose of propofol for the treatment of refractory migraine-like headaches in the emergency department setting
Dr Erik Wood0 个研究点目标入组 30 人开始时间: 2017年3月6日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Study of Favipiravir DPI in SARS-CoV-2 Infection.CTRI/2021/05/033750SAVA Healthcare Ltd60
进行中（未招募）
1 期
Survival Prolongation by Rationale Innovative GenomicsPatients with advanced/metastatic non-small cell lung cancer (NSCLC) with no documented targetable alterations (EGFR mutation, ALK translocation, ROS1 mutation if available or MET exon 14 skipping mutation if available)EUCTR2017-001455-32-FRWorldwide Innovative Network Association130
进行中（未招募）
1 期
Survival Prolongation by Rationale Innovative GenomicsPatients with advanced/metastatic non-small cell lung cancer (NSCLC) with no documented targetable alterations (EGFR mutation, ALK translocation, ROS1 mutation if available or MET exon 14 skipping mutation if available)EUCTR2017-001455-32-ESWorldwide Innovative Network Association130
已完成
2 期
A study of the effect of oral LAT8881 on acute migraine headacheACTRN12619001369112ateral Pharma Pty Ltd21
招募中
不适用
A pilot study to evaluate the Safety and Performance of the Percutaneuos Dynamic Stabilization (PDS) system for the treatment of mild to Moderate Degenerative Disc diseaseDegenarative diseases10005944NL-OMON30202mediqol24